Health Canada is planning to speed up reviews of some drugs by piggybacking on the decisions of foreign regulators, including ...

Y ou’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence ...

On Wednesday, radiology AI company Aidoc announced the FDA has cleared a tool that can triage 14 critical findings in a ...

Case counts remain far below the levels seen in 2022, but some experts are calling for research on the viability of an mpox ...

There have long been concerns about PSA testing due to overdiagnosis and overtreatment, and doctors still debate the test’s ...

An Italian oncologic psychologist warns these patients: “A prostatectomy doesn’t cure anxiety.” Emotional distress can be so ...

This writer is 24, in medical school — and is only now getting the HPV vaccine. The system failed her, she says.

From STAT’s Andrew Joseph: GSK said this morning that it would buy RAPT Therapeutics in a deal worth $2.2 billion, picking up ...

The principal deputy director of the CDC said he would not view the loss of the United States' measles elimination status as ...

Congressional appropriations committees offered a near-total rebuke of President Trump’s proposed downsizing and reshaping of ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

U.S. pharmaceutical companies are stepping up their campaign for higher drug prices in Europe, in some cases threatening to ...